province of Galapagos, Ecuador

Landscape Capital Management L.L.C. boosted its holdings in shares of Galapagos NV (NASDAQ:GLPG) by 27.5% during the 4th quarter, according to the ... and six have assigned a buy rating to the company. Galapagos currently has a consensus rating of “Hold” and an average target price of $111.00.

Finally, Zacks Investment Research upgraded Galapagos from a “sell” rating to a “hold” rating in a research report on Wednesday, January 3rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company. Galapagos ...

Finally, BidaskClub downgraded Galapagos from a sell rating to a strong sell rating in a research report on Saturday, December 2nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the company. Galapagos has an average ...

Finally, ValuEngine downgraded Galapagos from a “hold” rating to a “sell” rating in a report on Friday, December 1st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. Galapagos presently has a ...

Galapagos NV logo ValuEngine upgraded shares of Galapagos (NASDAQ:GLPG) from a sell rating to a hold rating in a report issued on Friday, February ... a hold rating and seven have assigned a buy rating to the company. Galapagos has an average rating of Buy and an average target price of $111.00.

... Stifel Nicolaus reaffirmed a buy rating and set a $120.00 price target on shares of Galapagos in a research report on Sunday, October 29th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. Galapagos ...

Finally, ValuEngine cut Galapagos from a hold rating to a sell rating in a report on Friday, December 1st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. Galapagos has a consensus rating of Buy and ...

Finally, BidaskClub cut Galapagos from a sell rating to a strong sell rating in a research note on Saturday, December 2nd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. Galapagos has an average ...

Gilead made a $425 million investment in Galapagos shares, which bought them 6,760,701 shares of Galapagos, 13.27% of the total number of outstanding shares. In addition to that, Gilead paid a $300M license payment and further payments up to $1.35B can come from royalties and profit sharing.

Biotech company Galapagos has opted to co-promote filgotinib with its partner Gilead Sciences should the drug be approved in Europe, according to a press release. Filgotinib is an investigational oral Janus kinase 1 (JAK1)-selective inhibitor under evaluation in Crohn's disease, ulcerative colitis and ...

In a previous note to my subscribers, I said that Galapagos NV (NASDAQ:GLPG) is a strong buy after Celgene's dramatic failure in Crohn's Disease or CD, because its lead candidate filgotinib is now the most advanced drug in anybody's CD pipeline. The Celgene (NASDAQ:CELG) drug was thought to ...

Vertex Pharmaceuticals Incorporated VRTX reported third-quarter 2017 earnings per share of 53 cents, which beat the Zacks Consensus Estimate of 37 cents and came ahead of the year-ago earnings of 17 cents. Strong product revenues led to higher profits in the quarter. Vertex reported revenues of ...

The stock price of NASDAQ-listed Belgian company Galapagos NV ADR (GLPG) started soaring mid-September onwards amid rumors of the company being a possible takeover target by Gilead Sciences Inc. (GILD). Following a 10-day long rally which resulted in a 35% spike in share price, the price is ...

Finally, Zacks Investment Research downgraded Galapagos from a hold rating to a sell rating in a research report on Wednesday, December 27th. One analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company. Galapagos currently has an ...

... target on shares of Galapagos in a research note on Sunday, October 29th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. Galapagos has an average rating of Buy and an average price target of $111.00.